Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic
- PMID: 32553759
- PMCID: PMC7832764
- DOI: 10.1053/j.gastro.2020.05.083
Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic
Comment in
-
Reply.Gastroenterology. 2021 Apr;160(5):1886-1887. doi: 10.1053/j.gastro.2021.01.020. Epub 2021 Jan 13. Gastroenterology. 2021. PMID: 33453233 Free PMC article. No abstract available.
Comment on
-
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.Gastroenterology. 2020 Aug;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032. Epub 2020 May 18. Gastroenterology. 2020. PMID: 32425234 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
